Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha

Nature
R HertzJ Bar-Tana

Abstract

Dietary fatty acids specifically modulate the onset and progression of various diseases, including cancer, atherogenesis, hyperlipidaemia, insulin resistances and hypertension, as well as blood coagulability and fibrinolytic defects; their effects depend on their chain length and degree of saturation. Hepatocyte nuclear factor-4alpha (HNF-4alpha) is an orphan transcription factor of the superfamily of nuclear receptors and controls the expression of genes that govern the pathogenesis and course of some of these diseases. Here we show that long-chain fatty acids directly modulate the transcriptional activity of HNF-4alpha by binding as their acyl-CoA thioesters to the ligand-binding domain of HNF-4alpha. This binding may shift the oligomeric-dimeric equilibrium of HNF-4alpha or may modulate the affinity of HNF-4alpha for its cognate promoter element, resulting in either activation or inhibition of HNF-4alpha transcriptional activity as a function of chain length and the degree of saturation of the fatty acyl-CoA ligands. In addition to their roles as substrates to yield energy, as an energy store, or as constituents of membrane phospholipids, dietary fatty acids may affect the course of a disease by modulating the expression of ...Continue Reading

References

May 11, 1991·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·W T Cave
Aug 1, 1980·Analytical Biochemistry·E DahlbergJ A Gustafsson
Sep 12, 1995·Proceedings of the National Academy of Sciences of the United States of America·S KerstenN Noy
Jan 1, 1994·Annual Review of Nutrition·S D Clarke, D B Jump
May 1, 1994·Prostaglandins, Leukotrienes, and Essential Fatty Acids·J P Chin
Apr 1, 1996·Molecular and Cellular Biology·S Malik, S K Karathanasis
Sep 1, 1996·Lipids·R E GossettF Schroeder
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·B M FormanR M Evans
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·S A KliewerJ M Lehmann

❮ Previous
Next ❯

Citations

Apr 30, 2003·Journal of Biochemical and Molecular Toxicology·Sree D PanugantiKathleen H Moore
Feb 25, 2005·Lipids·Manabu T NakamuraTakayuki Y Nara
Jan 5, 2002·Progress in Lipid Research·Mary C Hunt, Stefan E H Alexson
Jul 9, 1999·Progress in Lipid Research·C C DiRussoJ D Weimar
May 4, 2000·Progress in Lipid Research·A M MartelliL M Neri
Feb 8, 2003·Biochimica Et Biophysica Acta·Taro E Akiyama, Frank J Gonzalez
May 29, 2000·The Proceedings of the Nutrition Society·R UauyC Rojas
Oct 1, 2007·Animal : an International Journal of Animal Bioscience·A M Salter, E J Tarling
Apr 28, 2010·Nature Reviews. Nephrology·Xiaoxin X WangMoshe Levi
Aug 19, 2007·Molecular BioSystems·Daniel A BlasioleAlan D Attie
Apr 20, 2013·Food & Function·Yishai AviorYaakov Nahmias
Dec 17, 1998·The Biochemical Journal·K Yamada, T Noguchi
Mar 1, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·J BentzenM Fenger
Oct 7, 2009·The Journal of Biological Chemistry·Hidehisa TakahashiRonald C Conaway
Dec 15, 2005·The British Journal of Nutrition·Kazuhito SurugaToshinao Goda
Aug 18, 2004·Journal of the American College of Nutrition·Paola BenattiMenotti Calvani
Jun 10, 2009·Assay and Drug Development Technologies·Ken ShimamuraShigeru Tokita
Mar 14, 2002·Current Opinion in Lipidology·Donald B Jump
May 21, 2009·Current Opinion in Clinical Nutrition and Metabolic Care·Anne Marie Minihane

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.